Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX) - Hirani SP; Kassoumeri L; Mulligan K; Ruperto N; Woo P; Wedderburn LR; Newman SP (BMC, 2008)